HIV Medicine Association applauds crucial HIV/AIDS bill

May 18, 2006

The HIV Medicine Association (HIVMA) is pleased to see a key Senate committee putting medical care first in a new bill to reauthorize the Ryan White CARE Act, the federal government's largest program for uninsured or underinsured people living with HIV/AIDS.

However, the bill the Senate Health, Education, Labor and Pensions Committee approved yesterday could lead to rationing of medications unless it is funded appropriately. And it does nothing to reverse the growing shortage of qualified HIV care providers.

"Unlike 16 years ago, when the CARE Act was first written, people can live for decades with HIV--but only with the right medical care," said HIVMA Chair Daniel R. Kuritzkes, MD. "But currently the CARE Act does not give medical care the priority it deserves. This new reauthorizing bill helps to fix that problem by focusing on providing access to vital care to those in this country who, even today, aren't getting it."

Last April, HIVMA and the American Academy of HIV Medicine (AAHIVM) released joint recommendations designed to bring the CARE Act in line with today's HIV/AIDS epidemic, where fewer people are dying of AIDS but growing numbers are living with HIV and needing lifesaving medications and medical care.

HIVMA is pleased to see lawmakers have incorporated these recommendations into the bill. The bill, S. 2823, would require organizations receiving CARE Act funds to spend at least 75 percent on core medical services including physician's visits, medications, laboratory tests, and others--a list which very closely matches HIVMA and AAHIVM's priorities.

"Access to core medical services is one of the most important issues for patients," said Anita Vaughn, MD, an HIV physician in Newark, NJ, and chair of HIVMA's Ryan White CARE Act reauthorization work group. "But it's practically impossible to expect patients to stick to their drug therapy without managing other important issues as well, such as substance abuse and mental health concerns," Dr. Vaughn said. "We're extremely happy lawmakers recognized this and included substance abuse and mental health treatment as core medical services."

The bill includes another provision topping HIVMA's priority list: establishing a minimum set of anti-AIDS drugs for state AIDS Drug Assistance Programs (ADAPs) to offer. However, HIVMA is very concerned that there will be unintended consequences if the federal government fails to provide the additional funds needed.

"If the ADAPs are required to expand their medicine chests without getting any more money to do so," Dr. Kuritzkes said, "they may end up offering a wider variety of drugs but able to offer them to fewer patients." Chronic underfunding has already left some ADAPs with patients on waiting lists for drugs. More could find themselves in this situation, or having to cap the amount of medication a patient could receive. "ADAPs need much more funding to avoid worsening a situation HIVMA has called on lawmakers to end," Dr. Kuritzkes said.

Furthermore, the focus on care that legislators wrote into the reauthorization bill will be wasted if there aren't enough qualified HIV care providers to prescribe drugs, monitor resistance, deal with adverse reactions, watch vital organ function, and otherwise manage this extremely complex disease. HIV practices are closing as physicians burn out, retire, or close their practices due to under-funding and budget cuts. And very few physicians are stepping in to take their places.

"In many areas, it's becoming a crisis situation to find qualified medical providers to care for people with HIV/AIDS," Dr. Vaughn said. "New training programs are badly needed to entice young talent into the field." The bill misses an opportunity to address the shortage of qualified HIV care providers that is just around the corner.

The bill was drafted by leaders in both the Senate and the House of Representatives and has bipartisan support, which suggests it will move quickly. HIVMA calls on lawmakers to add provisions to fund training programs in HIV medicine and loan forgiveness programs in exchange for service in underserved areas and to guarantee that ADAPs have the federal support that they need to provide lifesaving medications to everyone with HIV in the United States who needs it.
For more information, visit the Ryan White CARE Act page on HIVMA's website,, under "Public Policy."

HIVMA is the professional home for more than 3,000 physicians, scientists and other health care professionals dedicated to the field of HIV/AIDS. Nested within the Infectious Diseases Society of America (IDSA), HIVMA promotes quality in HIV care and advocates policies that ensure a comprehensive and humane response to the AIDS pandemic informed by science and social justice. IDSA is a professional society representing about 8,000 physicians and scientists who specialize in infectious diseases. For more information, visit our websites: and

Infectious Diseases Society of America

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to